Skip to content

Advertisement

BMC Cardiovascular Disorders

  • Research article
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Protective effect of hydrogen-rich saline on pressure overload-induced cardiac hypertrophyin rats: possible role of JAK-STAT signaling

BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201818:32

https://doi.org/10.1186/s12872-018-0773-9

©  The Author(s). 2018

Received: 25 August 2017

Accepted: 7 February 2018

Published: 13 February 2018

Open Peer Review reports

Abstract

Background

Molecular hydrogen has been shown to have antioxidant effect and have been used to prevent oxidative stress-related diseases. The goal of this study was to explore if hydrogen-rich saline (HRS) plays a cardioprotective effect on abdominal aortic constriction (AAC) induced cardiac hypertrophy in rats. 60adult Sprague–Dawley rats received surgically the AAC for 6-week. After the surgery, the rats were randomly divided into 4 groups (15 for each):1: sham-operated (sham); 2: AAC-model; 3: AAC + Low HRS (LHRS); and 4: AAC + High HRS (HHRS). The rats in sham and AAC-model groups were treated with normal saline intraperitoneally, while rats in LHRS and HHRS groups were intraperitoneally treated with 3 or 6 mL/kg HRS daily, respectively, for 6-week.

Results

The ratios of HW/BW and LVW/BW were shown in an order of Model > LHRS > HHRS > SHAM groups. The cardiac hypertrophy was also manifested with increased expressions of atrial natriuretic peptide (ANP), brain natriuretic peptides (BNP) and fibrosis of cardiac tissues in AAC-model group, which could likewise be restrained in LHRS and HHRS groups. Moreover, the JAK-STAT (Janus Kinase-Signal transducers and activators of transcription) signaling molecule expressions were decreased with HRS treatment.

Conclusions

Our results showed a protective effect of HRS on pressure overload-induced cardiac hypertrophy in rats, which may be associated to a decreasing in JAK-STAT signaling pathway.

Keywords

  • HRS
  • Cardiac hypertrophy
  • Signaling pathway

Background

Cardiac hypertrophy is characterized by myocardial cell enlargement which involves physiological and pathological hypertrophy. End stage of pathological cardiac hypertrophy leads to heart failure and is associated with high mortality. Pathological cardiac hypertrophy contains the interstitial and perivascular fibrosis, apoptosis and the increased ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) synthesis. Hydrogen (H2) has been assayed in experimental settings in humans [1] to exert the protective effects against tissue damages including brain ischemia, neonatal brain hypoxia-ischemia, liver lesions, lung lesions, and myocardial ischemia/reperfusion injury through antioxidant activity [2–6]. Furthermore, HRS shows an anti-inflammatory effect [7], as reported that hydrogen-containing saline therapy ameliorated doxorubicin-induced cardiac hypertrophy and heart failure in rats [8]. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway triggers multiple signals involved in development, homeostasis and inflammation. The JAK-STAT signaling also plays a central role in transducing stress and growth signals in the hypertrophic heart. Ligand binding to receptors activates JAK and STAT proteins which are phosphorylated and form homo or heterodimers which then translocate into the nucleus where they regulate gene expression. In mammals, the JAK/STAT pathway transduces signals for a wide array of cytokines and growth factors including AngII, TNF-α, IL-1β, IL-6 and IFN-γ, all of which have been involved in cardiac hypertrophy.

Based on the previous study, we established a pressure overload-induced cardiac hypertrophy model in rats. We hypothesized that HRS prevents the cardiac hypertrophy in rats, which might be associated with decreased JAK-STAT signaling pathway. The anti-hypertrophic effect of HRS might restrain the progression of cardiac hypertrophy.

Methods

All the experiments were approved by the Animal Care Committee of Harbin Medical University (Heilongjiang, China).

HRS production

Hydrogen-rich saline was prepared as previous description [9]. Briefly, H2 was dissolved in 0.9% saline for 6 h under high pressure (0.4 MPa) to a supersaturated level using a HRS-producing apparatus. The saturated HRS was stored at 4 °C in an aluminum bag without dead volume and sterilized by gamma radiation. To confirm the concentration of hydrogen in the saline, gas chromatography was performed. HRS was freshly prepared every week to ensure a concentration of more than 0.6 mmol/L.

Cardiac hypertrophy model and animal grouping

Male Sprague–Dawley rats, weight 200–220 g, were provided from the Experimental Animal Center of The First Affiliated Hospital of Harbin Medical University (Harbin, China). Rats were housed with free access to food and water under a natural day/night cycle. Rats were acclimated for 7 days before any experimental procedures. All rats were cared according to Laboratory Animal Administration Rules (China, 2013).

Sixty rats were randomly divided into 4 groups: 1:sham-operated (sham); 2: AAC-model;3:AAC + Low HRS of 3 ml/kg(LHRS); and 4:AAC + High HRS of 6 ml/kg (HHRS) groups with 15 rats for each group. HRS was injected into the peritoneal cavityonce a day after surgery. The model of cardiac hypertrophy was established with the constriction of abdominal aorta as described previously [10]. Briefly, after the rat was anesthetized, and placed in supine position, a 2-cm incision along the midline of the abdomen was made. After the abdominal aorta was identified, an 8-cm length of 4–0 silk suture was passed underneath the abdominal aorta between the origins of the right and left renal arteries, and a knot was made around the aorta and a 22G needle, and then the needle was removed immediately to achieve a 0.7-mm diameter constriction. Sham-operated rats received a same surgical procedures without constriction performed.

At 6-week after AAC and HRS treatments, rats were weighed and then killed with a quick decollation. The hearts were soon removed, and rinsed in ice-cold PBS. The body weight, heart weight and the left ventricular weight were determined.

Histological analysis

The left ventricles were dissected and immersed in 4% paraformaldehyde overnight. Then the left ventricles were paraffin-embedded, and sectioned at a thickness of 4 μm. Masson staining were performed for light microscopy. The collagen volume fraction (CVF) was calculated as collagen area /total tissue area in a field.

Western blot analysis

The left ventricles were harvested and Western blot analysis was carried out as described previously [11], total protein concentration was determined by Bradford reagent (Bio-Rad), and the expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in left ventricles were determined with western blot. Briefly, about 50 μg of sample was separated by electrophoresis on a 4–12% SDS-polyacrylamide NuPAGE gradient gel (Invitrogen) and transferred to a PVDF membrane followed by probing with primary antibodies and followed by secondary antibodies. The protein bands were visualized using chemiluminescent substrates (Pierce). ANP and BNP antibodies (1/1000, respectively) were from Millipore (Temecula, CA) and antibodies of IL-6,JAK, STAT3 and p-STAT3were from Abcam (Cambridge, MA). Densitometry analysis of the bands was conducted with Scion Image Beta 4.02 software. The quantitative measurements of IL-6, JAK and STAT3 expression in the heart tissue were assessed with commercial ELISA kits following the manufacturer’s instructions. Absorbance was read on a microplate reader, and the concentrations were determined based on its standard curve. Native proteins from the left ventricles were isolated using Total Protein Extraction Kit (Biochain Institute, Inc.).

Apoptosis analysis

The apoptotic cells were detected byterminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay (Promega) according to manufacturer’s instructions. The apoptotic index’s quantification was conducted at 400 X. In all groups, 20 fields were randomly picked and the apoptotic index of each field was estimated as the percent of TUNEL-positive cells.

Statistics analysis

The data are expressed as mean ± S.D. Statistical analysis was performed with SPSS 11.5 (SPSS Inc., Chicago, IL, USA). Statistical comparisons were conducted through one-way analysis of variance with post hoc test of Student–Newman–Keuls. AP value of less than 0.05 was considered statistically significant.

Results

Cardiac hypertrophy and remodeling plays a critical role in the development of heart failure. Hypertensive heart disease is the key contributing factor of cardiac hypertrophy. To mimic these conditions, here we use a rat model whose abdominal aorta was constricted to increase the resistance of the left ventricle, and ultimately lead to a pressure overload in the heart. In this rat model, cardiac hypertrophy and remodeling were observed 6 weeks after the abdominal aortic constriction surgery. The averages of body weight, heart weight and left ventricle weight from each group were listed in Table 1. There were the increased ratios of HW/BW and LVW/BW in an order of model > LHRS>HHRS > SHAM groups (Fig. 1). The two different doses of HRS treatment for 6 weeks could prevent the cardiac hypertrophy, which was characterized with decreased ratios of HW/BW (Fig. 1a) and LVW/BW (Fig. 1b). The histological images of the hearts from the AAC-model group rats showed that the degrees of myocardial and perivascular fibrosis at the cross-section was significantly increased compared with the sham-operated rats, and the HRS-treated rats (Fig. 2). The levels of BNP, ANP (Fig. 3), JAK and IL-6 (Fig. 4) in the left ventricle tissue were markedly reduced in two-dose of HRS treated groups compared with AAC-model group. However, the levels of STAT3 were almost same among 4 groups, but p-STAT3 protein level was the highest in the AAC-model group, which was reduced with HRS treatment (Fig. 5).
Table 1

Comparison of body weight, heart mass weight and left ventricular weight

 

n

BW (g)

HW (mg) LVW (mg)

SHAM

15

309.15 ± 11.05

912 ± 34.38##626.57 ± 11.51##

MODEL

15

285.16 ± 8.04

1579.46 ± 65.38**835.13 ± 44.79**

HHRS

15

292.25 ± 5.451341.23 ± 58.72*

742.96 ± 17.59*

LHRS

15

296.75 ± 6.021130.22 ± 79.88#

701.56 ± 11.85#

The data were expressed as mean ± SD, n = 15.*P<0. 05, **P<0. 01 vs. Sham group; #P<0. 05, ##P<0. 01 vs. model group

Figure 1
Fig. 1

Effects of HRS on HW/BW (a) and LHW/BW (b) in each group. For all Figures, the quantitative data were expressed as mean ± SD, n = 15 per each group. *P<0.05, **P<0.01 vs. SHAM group; #P<0.05, ##P<0.01 vs. AAC-model group

Figure 2
Fig. 2

Upper panel: representative photomicrographs of left ventricle tissue with Masson staining (400× magnification). The AAC-model group showed the increased tissue interstitium and collagen protein expression (shown in blue color), while the LHRS and HHRS groups showed significantly less collagen protein expression. Low panel: quantitative calculation of collagen protein expression based on blue color volume

Figure 3
Fig. 3

The expression of ANP (a) and BNP (b) inthe left ventricle tissue was detected with western blot. Images from western blotting were on the right. The densitometry analyses of the bands, showing the ratio of ANP/beta-actin and BNP/beta-actin, were on the left. HRS treatment with 3 or 6 ml/kg reduced the expression of hypertrophy protein markers

Figure 4
Fig. 4

Expressions of IL-6 (a), JAK (b) and STAT3 (c) in left ventricle tissue. On the left columns, the absolute levels of IL-6, JAK and STAT3 were measured with Elisa. The middle columns were the representative western blot images, and the right columns were the ratios of densitometry analyses from western blot bends. HRS treatments were in 3 or 6 ml/kg

Figure 5
Fig. 5

HRS treatment reduced p-STAT3 levels in the left ventricle tissue. Western blotting analyses were performed on lysates from left ventricular tissues to assay p-STAT3. Compared with the sham-operated rats, the p-STAT3 expression levels in the AAC-treated rat hearts were significantly increased, which were prevented with treatment of HRS of 3 or 6 ml/kg

The apoptotic analysis showed that apoptosis levels were significantly increased in the heart of AAC-model rats. However the treatment of HRS significantly decreased the apoptosis compared with AAC-model rats (Fig. 6).
Figure 6
Fig. 6

HRS protected the cardio myocytes from apoptosis. The apoptosis levels in the hearts of AAC-model rat were significantly high, and this high level was prevented with treatment of HRS in 3 or 6 ml/kg, respectively. Low panel: images from TUNEL assay; Upper panel: quantitative calculation from the images

Discussion

The study showed that HRS remedy could prevent the process of cardiac hypertrophy, which is induced with cardiac pressure overload caused by AAC in a rat model. This conclusion was supported by the findings from histological and biochemistry studies. HRS reduced IL-6 levels and modulated cardiac cell activity in heart tissue. Furthermore, HRS reduced JAK-STAT signaling pathway, which has been shown to associate with heart hypertrophy.

In this model, the abdominal aorta is constricted above the renal arteries in rat to increase cardiac pressure overload and induce cardiac remodeling, hypertrophy and finally heart failure [12]. Decompensated cardiac remodeling were characterized by pulmonary congestion and right ventricular hypertrophy 6 weeks after AAB [13, 14]. This AAC rat model was characterized by using LVH and LV working disorders, along with hypertension.

In this study, we showed cardiac tissues remodeling which responds to pressure overload induced by constriction the abdominal aorta; these symptoms were reversed by HRS treatment. These outcomes indicate that HRS can reverse cardiac remodeling.

Hypertensive disease is the most frequent background of LVH, and anti-hypertensive remedy should not only reduce blood pressure but also lead to the regression of LVH [15, 16]. HRS decreasing cardiac hypertrophy in our study suggests that HRS can prevent against hypertensive cardiovascular events. Previous studies have concentrated on HRS’ effects on organ injury caused by ischemia/reperfusion; HRS can decrease apoptosis and inflammation in various kinds of diseases [17, 18]. However, the effect of HRS on cardiac hypertrophy stays unclear.

The JAK-STAT signaling pathway could increase the expression levels of genes which are related to cardiac hypertrophy [19, 20]. We hypothesized that the protective effects of HRS in the progression of pressure overload-induced cardiac hypertrophy might be in partially by lowering the JAK-STAT signaling pathway. In our animal model of cardiac hypertrophy, the activity and the expression level of several signal proteins were increased, including IL-6, JAK and p-STAT3. IL-6 was produced by neutrophils and activated macrophages and activates the inflammatory reaction. Gp130 is the common signal transducer used by the IL-6. The initiated intracellular signaling is strictly dependent on the function of gp130. Formation of gp130-containing complexes results in activation of intracellular JAKs. The phosphorylation of gp130 leads to dimerization of gp130 and activation of STAT1 and STAT3 as well as the JAK-STAT pathway. The activity of JAK-STAT signaling pathway was upregulated in the model group, which was downregulated by the treatment of HRS. In addition, the tissue IL-6 levelwas in accordance with the activity of the JAK-STAT signaling pathway. These results support our hypothesis.

Conclusion

In conclusion, this study demonstrated that HRS treatment can prevent cardiac hypertrophy and restrained the development of cardiac hypertrophy induced by pressure overload in rats, which may be associated to a decreasing in JAK-STAT signaling pathway.

Abbreviations

AAC: 

Abdominal aortic constriction

ANP: 

Atrial natriuretic peptide

BNP: 

Brain natriuretic peptides

HHRS: 

High hydrogen-rich saline

HRS: 

Hydrogen-rich saline

LHRS: 

Low hydrogen-rich saline

LVH: 

Left ventricular hypertrophy

Declarations

Acknowledgements

Not applicable.

Funding

This study was approved by Heilongjiang Education Hall Science and Technology Research Project(12531422).

Availability of data and materials

The datasets during the current study is available from the corresponding author on reasonable request.

Authors’ contributions

ZF and LF mainly participated in literature search, study design, writing and critical revision. YG, ZH, FX, SW, JY and LZ mainly participated in data collection, analysis and interpretation. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All the experiments were approved by the Animal Care Committee of Harbin Medical University (Heilongjiang, China).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Cardiovascular Medicine, First Affiliated Hospital of Harbin Medical University, Harbin, China
(2)
Emergency Department, Heilongjiang Provincial Hospital, Harbin, China

References

  1. Fontanari P, Badier M, Guillot C, Tomei C, Burnet H, Gardette B, et al. Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa hydra 10 record human dive. Eur J Appl Physiol. 2000;81:325–8.View ArticlePubMedGoogle Scholar
  2. Ohta S. Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nihon Ronen Igakkai Zasshi. 2008;45:355–62.PubMedGoogle Scholar
  3. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008;441:167–72.View ArticlePubMedGoogle Scholar
  4. Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, et al. Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2009;381:602–5.View ArticlePubMedGoogle Scholar
  5. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008;373:30–5.View ArticlePubMedGoogle Scholar
  6. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007;361:670–4.View ArticlePubMedGoogle Scholar
  7. Chen H, Sun YP, Li Y, Liu WW, Xiang HG, Fan LY, et al. Hydrogen-rich saline ameliorates the severity of l-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun. 2010;393:308–13.View ArticlePubMedGoogle Scholar
  8. Wu S, Zhu L, Yang J, Fan Z, Dong Y, Luan R, et al. Hydrogen-containing saline attenuates doxorubicin-induced heart failure in rats. Pharmazie. 2014;69:633–6.PubMedGoogle Scholar
  9. Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, et al. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009;1256:129–37.View ArticlePubMedGoogle Scholar
  10. Ku HC, Lee SY, Wu YA, Yang KC, Su MJ. A model of cardiac remodeling through constriction of the abdominal aorta in rats. J Vis Exp. 2016;Google Scholar
  11. Pfisterer L, Feldner A, Hecker M, Korff T. Hypertension impairs myocardin function: a novel mechanism facilitating arterial remodelling. Cardiovasc Res. 2012;96:120–9.View ArticlePubMedGoogle Scholar
  12. Daryadel A, Bogdanova A, Gassmann M, Mueller X, Zund G, Seifert B, et al. Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway. J Cardiothorac Surg. 2014;9:81.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Dhalla NS, Golfman L, Liu X, Sasaki H, Elimban V, Subcellular RH. Remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload. Ann N Y Acad Sci. 1999;874:100–10.View ArticlePubMedGoogle Scholar
  14. Gao S, Long CL, Wang RH, Wang H. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Cardiovasc Res. 2009;83:444–56.View ArticlePubMedGoogle Scholar
  15. van Zwieten PA. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy. Cardiovasc Res. 2000;45:82–91.View ArticlePubMedGoogle Scholar
  16. Walsh JA 3rd, Prineas R, Daviglus ML, Ning H, Liu K, Lewis CE, et al. Prevalence of electrocardiographic abnormalities in a middle-aged, biracial population: Coronary Artery Risk Development in Young Adults study. J Electrocardiol. 2010;43(385):e1–9.Google Scholar
  17. Buchholz BM, Kaczorowski DJ, Sugimoto R, Yang R, Wang Y, Billiar TR, et al. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant. 2008;8:2015–24.View ArticlePubMedGoogle Scholar
  18. Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006;114:2474–81.View ArticlePubMedGoogle Scholar
  19. Yan L, Liang QS, Yong YQ, Yong-Sheng LI, Zheng Z. The effect of tanshinone II a on JAK/STAT pathway of rat hypertrophic model induced by abdominal aorta coarctation in rats. J Pract Med. 2008;13:2199–201.Google Scholar
  20. Banerjee I, Fuseler JW, Intwala AR, Baudino TA. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol. 2009;296:H1694–704.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us